Screening non-small cell lung cancer patient-derived organoids with epigenetic probes reveals PRMT5 as an oncogenic target

被引：0
|
作者：
Jafarova, Khadija
Li, Quan
Radulovich, Nikolina
Liu, Geoffrey
Tsao, Ming S.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 06期
关键词：
D O I：
10.1158/1538-8514.SYNTHLETH24-B026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B026
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer
    O'Leary, Karen
    Shia, Alice
    Schmid, Peter
    CURRENT CANCER DRUG TARGETS, 2018, 18 (01) : 89 - 96
  • [42] Patient-derived organoids from surgically treated, localized non-small cell lung cancer as high-throughput drug testing platforms for conventional and repurposed drugs
    Manjunath, Yariswamy
    Nagaraj, Suvilesh Kanve
    Nussbaum, Yulia I.
    Gadelkarim, Mohamed
    Staveley-O'Carroll, Kevin F.
    Kimchi, Eric T.
    Li, Guangfu
    Warren, Wesley
    Shyu, Chi-Ren
    Ciorba, Matthew
    Mitchem, Jonathan B.
    Kaifi, Jussuf T.
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Multi-region patient-derived xenograft models from non-small cell lung cancer patients enrolled in lung TRACERx
    Hynds, Robert E.
    Pearce, David R.
    Akarca, Ayse U.
    Ward, Sophia
    Huebner, Ariana
    Pich, Oriol
    Wilson, Gareth A.
    Gowers, Kate H.
    Towns, Rebecca
    Ben Aissa, Assma
    Veeriah, Selvaraju
    Quezada, Sergio A.
    Jamal-Hanjani, Mariam
    Janes, Sam M.
    McGranahan, Nicholas
    Moore, David A.
    Marafioti, Teresa
    Swanton, Charles
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Investigations on non-small cell lung cancer screening
    Du, Xuedong
    Ji, Jiasong
    Song, Jingjing
    Zhao, Zhongwei
    Tu, Jianfei
    Fan, Xiaoxi
    Tang, Xing
    Lou, Da
    Tao, Hongmei
    Lin, Yue
    Yu, Chris Chang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer
    Shi, Bin
    Behrens, Carmen
    Vaghani, Viralkumar
    Riquelme, Erick Marcelo
    Rodriguez-Canales, Jaime
    Kadara, Humam
    Lin, Heather
    Lee, Jack
    Liu, Hui
    Wistuba, Ignacio
    Simon, George
    CANCER MEDICINE, 2019, 8 (14): : 6383 - 6392
  • [46] Phenotype Mapping of Patient-Derived Small Cell Lung Cancer Organoids Illuminate Subtype-Specific Therapeutic Vulnerability
    Fukushima, T.
    Yasuda, H.
    Terai, H.
    Hamamoto, J.
    Okada, M.
    Saito, A.
    Takaoka, H.
    Ito, F.
    Shigematsu, L.
    Nukaga, S.
    Ohgino, K.
    Ikemura, S.
    Kawada, I.
    Soejima, K.
    Fukunaga, K.
    Sato, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S195 - S195
  • [47] New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Brahmer, Julie R.
    Kelly, Ronan J.
    CLINICAL CANCER RESEARCH, 2014, 20 (09) : 2244 - 2248
  • [48] Imaging of the patient with non-small cell lung cancer
    Munden, RF
    Swisher, SS
    Stevens, CW
    Stewart, DJ
    RADIOLOGY, 2005, 237 (03) : 803 - 818
  • [49] Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration
    Fuchs, Vered
    Sobarzo, Ariel
    Msamra, Maha
    Kezerle, Yarden
    Linde, Liat
    Sevillya, Gur
    Anoze, Alaa
    Refaely, Yael
    Cohen, Ahron Yehonatan
    Melamed, Israel
    Azriel, Amit
    Shoukrun, Rami
    Raviv, Yael
    Porgador, Angel
    Peled, Nir
    Roisman, Laila Catalina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (09): : 2227 - 2239
  • [50] Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts
    J. Rolff
    M. Becker
    J. Merk
    J. Hoffmann
    I. Fichtner
    Targeted Oncology, 2016, 11 : 507 - 514
12345